These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
333 related items for PubMed ID: 14712422
21. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions. Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM. Rev Assoc Med Bras (1992); 2024; 70(4):e20230871. PubMed ID: 38716932 [Abstract] [Full Text] [Related]
22. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]
23. Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Hamasaki Y, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Yata N, Kaneko T, Honda M, Japanese Study Group of Renal Disease. Pediatr Nephrol; 2009 Nov; 24(11):2177-85. PubMed ID: 19714370 [Abstract] [Full Text] [Related]
24. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis. Yorgin PD, Belson A, Higgins J, Alexander SR. Am J Kidney Dis; 2001 Jun; 37(6):E44. PubMed ID: 11382715 [Abstract] [Full Text] [Related]
25. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A. Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410 [Abstract] [Full Text] [Related]
26. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. Ramachandran R, Kumar V, Rathi M, Nada R, Jha V, Gupta KL, Sakhuja V, Kohli HS. Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498 [Abstract] [Full Text] [Related]
27. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis. Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS. Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086 [Abstract] [Full Text] [Related]
28. Clinical Trials in FSGS: Past Challenges and New Trial Designs. Gipson D. Semin Nephrol; 2016 Nov; 36(6):453-459. PubMed ID: 27987544 [No Abstract] [Full Text] [Related]
29. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study. Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G. Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493 [Abstract] [Full Text] [Related]
30. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Bagga A, Hari P, Moudgil A, Jordan SC. Am J Kidney Dis; 2003 Dec; 42(6):1114-20. PubMed ID: 14655181 [Abstract] [Full Text] [Related]
31. [Nephrotic syndrome refractory to conventional therapy]. Ragazzoni E, Agliata S, Airoldi G, Fortina F, Sacco A, Schweiger K, Tommasini G, Cavagnino A. Minerva Urol Nefrol; 1999 Jun; 51(2):89-94. PubMed ID: 10429418 [Abstract] [Full Text] [Related]
32. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis. Chiou YY, Lee YC, Chen MJ. Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233 [Abstract] [Full Text] [Related]
33. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study. Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Radin M, Barreca A, Fenoglio R, Baldovino S, Menegatti E. Am J Nephrol; 2017 Aug; 46(2):108-113. PubMed ID: 28700988 [Abstract] [Full Text] [Related]
34. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Westhoff TH, Schmidt S, Zidek W, Beige J, van der Giet M. Clin Nephrol; 2006 Jun; 65(6):393-400. PubMed ID: 16792133 [Abstract] [Full Text] [Related]
35. [The effect of cyclosporine A in steroid-dependent nephrotic syndrome in children]. Wasilewska A, Zoch-Zwierz W, Tomaszewska B, Tenderenda E. Pol Merkur Lekarski; 2005 Feb; 18(104):168-72. PubMed ID: 17877123 [Abstract] [Full Text] [Related]
36. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series. Madan A, Mijovic-Das S, Stankovic A, Teehan G, Milward AS, Khastgir A. BMC Nephrol; 2016 Mar 31; 17():37. PubMed ID: 27036111 [Abstract] [Full Text] [Related]
37. Long-term ciclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Ittel TH, Clasen W, Fuhs M, Kindler J, Mihatsch MJ, Sieberth HG. Clin Nephrol; 1995 Sep 31; 44(3):156-62. PubMed ID: 8556831 [Abstract] [Full Text] [Related]
38. Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis. Hamasaki Y, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ishikura K, Ito S, Kaneko T, Honda M, for Japanese Study Group of Renal Disease in Children. Pediatr Nephrol; 2013 May 31; 28(5):765-71. PubMed ID: 23314441 [Abstract] [Full Text] [Related]
39. Abatacept experience in steroid and rituximab-resistant focal segmental glomerulosclerosis. Jayaraman VK, Thomas M. BMJ Case Rep; 2016 Feb 17; 2016():. PubMed ID: 26887886 [Abstract] [Full Text] [Related]
40. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients]. Cao Q, Huang WY, Xu H, Zhou LJ. Zhonghua Er Ke Za Zhi; 2008 Sep 17; 46(9):698-701. PubMed ID: 19099862 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]